Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.288 SEK | -4.00% |
|
-4.00% | +6.27% |
05-24 | Xintela AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-23 | Xintela and EQGen Biomedical to Collaborate to Develop EQSTEM Stem Cell Treatment for Horses | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
16.05M | - | - | - | - | - | |
45.51B | - | |||||
38.52B | ||||||
38.13B | ||||||
30.74B | - | |||||
26.03B |
- Stock Market
- Equities
- XINT Stock
- Charts Xintela AB
- Sector Chart